Citation Impact
Citing Papers
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Consequences of antiepileptic drug withdrawal: A randomized, double‐blind study (Akershus Study)
2007
Parkinson's disease
2009 Standout
Diagnostic criteria for multiple sclerosis
2001 Standout
Banana (Musa spp) from peel to pulp: Ethnopharmacology, source of bioactive compounds and its relevance for human health
2014 Standout
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates
2005
Motor fluctuations in Parkinson's disease: pathophysiology and treatment
1999
A Randomized, Double-blind, Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
2001
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Subcutaneous Apomorphine
2004
Management of Parkinson's disease: An evidence-based review
2002
ILAE Official Report: A practical clinical definition of epilepsy
2014 Standout
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
2020
Works of Lauge Østergaard being referenced
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
2020
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.
1995